SuperX AI Technology Ltd SUPX
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-1.41
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.6M | $2.9M | $6.1M | $9.6M | — |
| Cost of revenue | $3.2M | $2.1M | $4.9M | $8.2M | — |
| Gross profit | $365.4K | $817.9K | $1.3M | $1.4M | — |
| R&D | $1.2M | — | — | — | — |
| SG&A | $11.8M | $1.8M | $1.4M | $1.6M | — |
| Total operating expenses | $21.7M | $1.9M | $1.4M | $1.7M | — |
| Operating income | -$21.4M | -$1.0M | -$98.6K | -$224.4K | — |
| Pre-tax income | -$21.2M | -$847.6K | $94.6K | -$12.1K | — |
| Income tax | $35.0K | $7.3K | $56.0K | $53.9K | — |
| Net income | -$21.2M | -$854.9K | $38.7K | -$65.9K | — |
| EPS, basic | -1.41 | -0.08 | 0.00 | -0.01 | — |
| EPS, diluted | -1.41 | -0.08 | 0.00 | -0.01 | — |
| Shares, diluted (wtd. avg.) | 15.1M | 11.1M | 10.7M | 10.7M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | $17.2M | $7.2M | $558.4K | $999.2K | $1.0M |
| Receivables | $185.1K | $257.6K | $767.0K | — | — |
| Total current assets | $39.0M | $7.9M | $1.4M | — | — |
| Property, plant and equipment | $246.4K | $18.8K | $22.8K | — | — |
| Total assets | $52.1M | $8.0M | $2.5M | — | — |
| Accounts payable | $416.1K | $451.2K | $752.5K | — | — |
| Short-term debt | — | $164.7K | $151.5K | — | — |
| Total current liabilities | $31.8M | $953.5K | $1.1M | — | — |
| Long-term debt | $576.0K | $245.4K | $237.3K | — | — |
| Total liabilities | $32.2M | $1.0M | $1.4M | — | — |
| Retained earnings | -$22.3M | -$1.1M | -$247.3K | — | — |
| Total equity | $19.8M | $7.0M | $1.1M | $1.2M | $1.5M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$8.3M | -$751.7K | $45.1K | -$229.1K | — |
| Depreciation and amortisation | $82.9K | $10.6K | $9.8K | $22.2K | — |
| Stock-based compensation | $3.6M | — | — | — | — |
| Capital expenditure | $301.0K | $6.5K | $14.6K | $11.4K | — |
| Investing cash flow | -$12.4M | -$6.5K | -$14.6K | -$11.4K | — |
| Financing cash flow | $30.7M | $7.4M | -$473.3K | $209.1K | — |
| Dividends paid | — | — | $153.1K | $174.4K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-25-104687.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $9.6M | $6.1M | $2.9M | $3.6M |
| Gross profit | — | $1.4M | $1.3M | $817.9K | $365.4K |
| Net income | — | -$65.9K | $38.7K | -$854.9K | -$21.2M |
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| G | Genpact LTD | $6.86B | 13.0x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.34B | 19.1x | 2.4% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |